Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
Medicare Should Cover Wegovy — but Not Negotiate Its Price
Subjecting Wegovy to price controls would crush innovation and discourage new entrants to this important new class of anti-obesity medications that could help millions of Americans.
Posted in -
Medicare Enrollment Linked to Sharp Decline in Use of Mental Healthcare Services
People with substantial mental health needs appear to receive much less mental healthcare after they age into Medicare, while use of non-mental healthcare is unaffected.
Posted in -
Out-Of-Network Utilization and Plan Selection Among Medicare Advantage Cost Plan Enrollees
Provider networks in Medicare Advantage not only appear to impact health care use but can also impact the types of beneficiaries who choose to enroll in traditional Medicare versus MA.
Posted in -
Enrollment in Medicare is Associated with Fewer Outpatient Mental Healthcare Visits among Those with Mental Health Symptoms
Enrolling in Medicare is associated with a reduction in the use of mental healthcare among individuals with probable mental health symptoms and low or moderate family incomes.
Posted in
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Experts On Medicare and Medicaid
Our Work In Medicare and Medicaid
-
Government Needs to Do More to Ensure Obesity Drug Safety
Expanding coverage for anti-obesity medications without reforming compounding regulation will exacerbate problems with counterfeit drugs. The incoming administration should modernize manufacturing techniques, shore up the supply chain and ban compounding of new obesity medications.
Categorized in -
Comments to CMS on Proposed $2 Drug List Model
Transparent, simple plan benefits like the proposed model, as well as transparent cost structures throughout the system, have valuable impacts for the beneficiary and the potential to help align incentives throughout the distribution system.
Categorized in -
Medicare Advantage Costs Taxpayers 22% More Per Enrollee. Here’s How Payment Reform Could Help Close the Gap.
The Medicare Advantage payment system needs a broad reform that aligns insurers’ incentives with the needs of beneficiaries and taxpayers.
Categorized in -
How Specialized Are Special Needs Plans? Evidence from Provider Networks
Although envisioned as a way to coordinate benefits between Medicare and Medicaid and serve the specific needs of the dually eligible population, only 46 percent of D-SNP plans feature distinct provider networks from standard MA plans offered by the same insurer.
Categorized in -
Medicare Part D Beneficiaries’ Self-reported Barriers to Switching Plans and Making Plan Comparisons at All
Over half of Medicare beneficiaries in stand-alone Part D plans kept their coverage without comparing plans during the last enrollment period, and many reported not knowing how to switch plans.
Categorized in -
Most Medicare Beneficiaries Do Not Compare Prescription Drug Plans – And May Be Sticking with Bad Plans
Over half of Medicare beneficiaries in stand-alone Part D plans kept their coverage without comparing plans during the last enrollment period, and many reported not knowing how to switch plans.
Categorized in